Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1924

1.

How to Think - Not Feel - about Tobacco Harm Reduction.

Warner KE.

Nicotine Tob Res. 2018 Apr 30. doi: 10.1093/ntr/nty084. [Epub ahead of print]

PMID:
29718475
2.

Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.

Elias J, Hendlin YH, Ling PM.

PLoS Med. 2018 May 1;15(5):e1002562. doi: 10.1371/journal.pmed.1002562. eCollection 2018 May.

3.

Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015).

Coleman B, Rostron B, Johnson SE, Persoskie A, Pearson J, Stanton C, Choi K, Anic G, Goniewicz ML, Cummings KM, Kasza KA, Silveira ML, Delnevo C, Niaura R, Abrams DB, Kimmel HL, Borek N, Compton WM, Hyland A.

Tob Control. 2018 Apr 25. pii: tobaccocontrol-2017-054174. doi: 10.1136/tobaccocontrol-2017-054174. [Epub ahead of print]

PMID:
29695458
4.

Vape shops: who uses them and what do they do?

Pattinson J, Lewis S, Bains M, Britton J, Langley T.

BMC Public Health. 2018 Apr 23;18(1):541. doi: 10.1186/s12889-018-5467-9.

5.

Slower nicotine metabolism among postmenopausal Polish smokers.

Kosmider L, Delijewski M, Koszowski B, Sobczak A, Benowitz NL, Goniewicz ML.

Pharmacol Rep. 2017 Nov 22;70(3):434-438. doi: 10.1016/j.pharep.2017.11.009. [Epub ahead of print]

PMID:
29627689
6.

E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation.

Warner KE, Mendez D.

Nicotine Tob Res. 2018 Mar 29. doi: 10.1093/ntr/nty062. [Epub ahead of print]

PMID:
29617887
7.

Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes.

Filippidis FT, Laverty AA, Mons U, Jimenez-Ruiz C, Vardavas CI.

Tob Control. 2018 Mar 21. pii: tobaccocontrol-2017-054117. doi: 10.1136/tobaccocontrol-2017-054117. [Epub ahead of print]

8.

Lipid-drug-conjugate (LDC) solid lipid nanoparticles (SLN) for the delivery of nicotine to the oral cavity - optimization of nicotine loading efficiency.

Ding Y, Nielsen KA, Nielsen BP, Bøje NW, Müller RH, Pyo SM.

Eur J Pharm Biopharm. 2018 Mar 12. pii: S0939-6411(17)31223-7. doi: 10.1016/j.ejpb.2018.03.004. [Epub ahead of print]

PMID:
29545120
9.

Evolution of Electronic Cigarette Brands From 2013-2014 to 2016-2017: Analysis of Brand Websites.

Hsu G, Sun JY, Zhu SH.

J Med Internet Res. 2018 Mar 12;20(3):e80. doi: 10.2196/jmir.8550.

10.

Tobacco use prevalence and smoking cessation pharmacotherapy prescription patterns among hospitalized patients by medical specialty.

Srivastava AB, Ramsey AT, McIntosh LD, Bailey TC, Fisher SL, Fox L, Castro M, Ma Y, Baker TB, Chen LS, Bierut LJ.

Nicotine Tob Res. 2018 Feb 22. doi: 10.1093/ntr/nty031. [Epub ahead of print]

PMID:
29481616
11.

Advancing Tobacco Product Warning Labels Research Methods and Theory: A Summary of a Grantee Meeting Held by the US National Cancer Institute.

Thrasher JF, Brewer NT, Niederdeppe J, Peters E, Strasser AA, Grana R, Kaufman AR.

Nicotine Tob Res. 2018 Feb 10. doi: 10.1093/ntr/nty017. [Epub ahead of print]

PMID:
29444268
12.

Pharmacist prescriptive authority for smoking cessation medications in the United States.

Adams AJ, Hudmon KS.

J Am Pharm Assoc (2003). 2018 May - Jun;58(3):253-257. doi: 10.1016/j.japh.2017.12.015. Epub 2018 Feb 14.

PMID:
29426612
13.

Dual Use of E-Cigarettes and Traditional Cigarettes Among Adolescents in Taiwan, 2014-2016.

Chen PC, Chang LC, Hsu C, Lee YC.

Nicotine Tob Res. 2018 Feb 2. doi: 10.1093/ntr/nty003. [Epub ahead of print]

PMID:
29425383
14.

Randomized Trial to Compare Smoking Cessation Rates of Snus, with and without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.

Nelson PR, Chen P, Battista DR, Pillitteri JL, Shiffman S.

Nicotine Tob Res. 2018 Jan 24. doi: 10.1093/ntr/nty011. [Epub ahead of print]

PMID:
29373698
15.

Urinary Metabolite Levels of Flame Retardants in Electronic Cigarette Users: A Study Using the Data from NHANES 2013-2014.

Wei B, Goniewicz ML, O'Connor RJ, Travers MJ, Hyland AJ.

Int J Environ Res Public Health. 2018 Jan 25;15(2). pii: E201. doi: 10.3390/ijerph15020201.

16.

Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.

Sukhija M, Srivastava R, Kaushik A.

Int J Clin Pharmacol Ther. 2018 Mar;56(3):113-119. doi: 10.5414/CP203097.

17.

E-Cigarettes and the Harm-Reduction Continuum.

Fairchild AL, Lee JS, Bayer R, Curran J.

N Engl J Med. 2018 Jan 18;378(3):216-219. doi: 10.1056/NEJMp1711991. No abstract available.

PMID:
29342380
18.

Risk of coronary heart disease among smokeless tobacco users: results of systematic review and meta-analysis of global data.

Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R.

Nicotine Tob Res. 2018 Jan 9. doi: 10.1093/ntr/nty002. [Epub ahead of print]

PMID:
29325111
19.

Health Effects and Dependency Associated with Snuff Consumption [Internet].

Natvig Norderhaug I, Dybing E, Gilljam H, Lind PO, Lund KE, Mørland J, Stegmayr B, Hofmann B, Ørjasæter Elvsaas IK.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Jun.

20.

Lung Cancer: Smoking Cessation.

Latimer KM.

FP Essent. 2018 Jan;464:11-16. Review.

PMID:
29313652

Supplemental Content

Loading ...
Support Center